期刊档案 · INTEGRATIVE & COMPLEMENTARY MEDICINE

World Journal of Acupuncture-Moxibustion

ISSN 1003-5257 · eISSN 2773-0751 · Elsevier

World Journal of Acupuncture-Moxibustion 中科院 医学 4区(2025 年升级版),影响因子 1.1(官网公布),完全开放获取,APC 约 1,000 美元,2025 年发文 50 篇,ESCI、Scopus 收录。

影响因子1.1期刊官网公布的最新值
中科院分区医学 4区2025 年升级版大类 · 2026 新锐版 医学 3区
审稿周期—暂无反馈
版面费1,000 USD完全开放获取
录用比例—暂无反馈
年发文量50 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

World Journal of Acupuncture-Moxibustion 由 Elsevier 出版,属中科院医学大类(2025 升级版4区)。按 OpenAlex 近年发文统计,该刊主要发表 Acupuncture Treatment Research Studies、Healthcare and Venom Research、Traditional Chinese Medicine Studies 等主题的论文,这 3 个主题约占 62.4%,主导子领域为 Complementary and alternative medicine、Neurology。(根据 OpenAlex 主题统计与中科院分区数据生成)

Original articles and reviews of clinical practice, scientific research, literature, theory and education of acupuncture medicine worldwide. limited, the focus of the journal includes, but is not confined to, clinical researches, case reports, summaries of clinical experiences, experimental researches, literature researches, theory researches, teaching researches, reviews, perspectives, standards and guidelines on acupuncture, moxibustion, tuina, cupping, massage, etc.

摘自期刊官网 Aims & Scope

研究方向(LetPub):INTEGRATIVE & COMPLEMENTARY MEDICINE

主编 Xiao-chun Yu出版商官网

编委会国家分布:中国大陆 39 位(约 63%);主要国家 中国 39、美国 10、韩国 3、中国香港 2、英国 2(共 62 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Acupuncture Treatment Research StudiesMedicine31.6%
  2. Healthcare and Venom ResearchMedicine16.8%
  3. Traditional Chinese Medicine StudiesMedicine14%
  4. Medical Research and TreatmentsMedicine6.7%
  5. Myofascial pain diagnosis and treatmentBiochemistry, Genetics and Molecular Biology4%
  6. Complementary and Alternative Medicine StudiesMedicine3.3%
  7. Botulinum Toxin and Related Neurological DisordersMedicine2.2%
  8. Facial Nerve Paralysis Treatment and ResearchMedicine2%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)医学 4 区
类别学科分区
大类医学4 区
小类全科医学与补充医学INTEGRATIVE & COMPLEMENTARY MEDICINE4 区

Top 期刊:否综述期刊:否

《新锐期刊分区表》( 2026年3月发布)医学 3 区
类别学科分区
大类医学3 区
小类全科医学与补充医学INTEGRATIVE & COMPLEMENTARY MEDICINE3 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)医学 4 区
类别学科分区
大类医学4 区
小类全科医学与补充医学INTEGRATIVE & COMPLEMENTARY MEDICINE4 区

Top 期刊:否综述期刊:否

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

Web of ScienceEmbase出版商官网

其他:CNKI、Science Direct (SD)、Chinese Science Citation Database (CSCD)、Japan Science and Technology Agency (JST)、China National Knowledge Infrastructure (CNKI)

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
1.1出版商官网 ·
CiteScore 2026-06
1.7LetPub ·
CiteScore(出版商公布)
1.7出版商官网 ·
SJR 2026-06
0.26LetPub ·
SNIP 2026-06
0.38LetPub ·
h-index
15OpenAlex ·
i10-index
51OpenAlex ·
两年平均被引
1.22OpenAlex ·
自引率
36.4%LetPub ·
Gold OA 文章占比
65.71%LetPub ·

发文规模

年文章数
46LetPub ·

逐年发文量 OpenAlex 统计 · 累计 2,242 篇 · 当年数据不完整

年份发文量其中 OA被引
202637373
2025505074
2024454584
20235019143
2022503176
2021650174

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

投稿到发表(期刊自报)
约 30 周DOAJ ·
评审方式
双盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 1,000有CC BY-NC-ND
OpenAlexUSD 0——
出版商官网USD 1,000——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点3 项,摘自作者指南
摘要
≤ 800 词
关键词
3–5 个
参考文献格式
顺序编码制(按引用顺序编号)
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型14 种
  1. academic discussionArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  2. brief communicationArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  3. brief communicationsArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  4. case reportArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  5. case reportsArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  6. editorialArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  7. guidelinesArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  8. invited articlesArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  9. original researchesArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  10. perspectiveArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  11. perspectivesArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  12. reviewArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  13. reviewsArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
  14. standardsArticle types considered for publication include original researches (clinical researches, experimental researches, literature researches, theory researches, te…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、查重
AI 使用 Declaration of generative AI in scientific writing

作者在投稿时被鼓励声明在科学写作中使用生成式人工智能;该指南仅针对写作过程,生成式AI只能用于提高稿件的可读性和语言,且必须在人类监督和控制下应用,作者应仔细审查和编辑结果。 模型中文摘要

Authors is encouraged to declare the use of generative AI in scientific writing upon submission of the paper. The following guidance refers only to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process: Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language of…

原文 ↗出版商官网 ·
作者资格 Authorship

为透明起见,期刊要求作者提交作者声明文件,使用相关CRediT角色(如概念化、数据管理、方法学等)概述各自对论文的贡献,声明格式为作者姓名在前、CRediT角色在后。 模型中文摘要

For transparency, we require authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editi…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

自2024年1月起,所有作者必须披露可能不当影响或偏倚其工作的与他人或组织的财务和个人关系,包括雇佣、咨询、持股、酬金、付费专家证言、专利申请或注册、资助以及与期刊的编辑或顾问委员会成员隶属关系等潜在竞争利益。 模型中文摘要

Starting from January 2024, all authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as…

原文 ↗出版商官网 ·
出版伦理 Ethical Approval of Studies and Informed Consent

涉及人或动物的实验研究须获得适当的机构审查委员会或伦理委员会批准,批准信息(包括官方批准代码)应在稿件的方法部分说明;没有正式伦理审查委员会的研究者应遵循《赫尔辛基宣言》的原则。 模型中文摘要

For human or animal experimental investigations, appropriate institutional review board or ethics committee approval is required, and such approval, including the official approval code, should be stated in the methods section of the manuscript. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World …

原文 ↗出版商官网 ·
许可与版权 Copyright

文章被接受后,作者将被要求填写“期刊出版协议”,相应作者会收到确认收到稿件的电子邮件,并附有该协议表格或在线版本链接。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

原文 ↗出版商官网 ·
开放获取 Open access

该期刊发表的每篇同行评审研究文章均以开放获取形式出版,文章在出版后立即通过互联网永久免费获取;作者或其资助者/机构需支付文章出版费(APC),本刊APC为1000美元另加增值税。 模型中文摘要

Open access every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. To provide open access, this journal has an open access fee (also known as an article publishing charge APC) which needs to be paid by th…

原文 ↗出版商官网 ·
同行评审 Peer review

该期刊采用双盲同行评审流程,投稿先由编辑评估是否适合发表,适合的稿件通常送至少两名独立专家评审以评估科学质量,接受或拒绝的决定由编辑作出且为最终决定。 模型中文摘要

This journal follows a double anonymized review process. Your submission will initially be assessed by our editors to determine suitability for publication in this journal. If your submission is deemed suitable, it will typically be sent to a minimum of two independent expert reviewers to assess the scientific quality. The decision as to whether your article is accepted or rejected will be taken b…

原文 ↗出版商官网 ·
查重

提交至KeAi期刊的稿件会在编辑系统内自动使用iThenticate的CrossCheck进行筛查,以检测包括重叠和相似文本在内的抄袭问题。 模型中文摘要

Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Elsevier
ISSN
1003-5257
电子版 ISSN
2773-0751
官方链接

常见问题

关于 World Journal of Acupuncture-Moxibustion 的常见问题

World Journal of Acupuncture-Moxibustion 是中科院几区期刊?

2025 年升级版分区表中,World Journal of Acupuncture-Moxibustion 为医学 4区,小类 全科医学与补充医学 4 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。

World Journal of Acupuncture-Moxibustion 的影响因子是多少?

期刊官网公布的影响因子为 1.1,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 1.7,h-index 为 15。

World Journal of Acupuncture-Moxibustion 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 800 词;关键词:3–5 个;参考文献格式:顺序编码制(按引用顺序编号)。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

World Journal of Acupuncture-Moxibustion 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 62 位编委中,中国大陆 39 位(约 63%);人数最多的国家是 中国(39 位)、美国(10 位)、韩国(3 位)。统计按编委会页面列出的机构国家计,仅供参考。

World Journal of Acupuncture-Moxibustion 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,World Journal of Acupuncture-Moxibustion 被 ESCI、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、Embase 收录,该清单未与各数据库逐一核对。

World Journal of Acupuncture-Moxibustion 是开放获取期刊吗?版面费多少?

World Journal of Acupuncture-Moxibustion 为完全开放获取。APC 约 1,000 美元。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。